Metagenomi Therapeutics, Inc.MGX
Metagenomi Therapeutics, Inc. Award Timing Disclosure Disclosure
During 2024, our compensation committee did not take into account any material nonpublic information when determining the timing and terms of equity incentive awards, and we did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. During 2024, we did not grant stock options to our NEOs during any period beginning four business days before and ending one business day after the filing or furnishing of a Form 10-Q, 10-K or 8-K that discloses material nonpublic information.
Free Sentinel
Track for freeWant the next Metagenomi Therapeutics, Inc. award timing disclosure disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Metagenomi Therapeutics, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.